Amir Shojaei compensation by year
HARROW Summary Compensation Table · the one fiscal year held| Component | FY2025 |
|---|---|
| Salary | $441,346 |
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $670,569 |
| Non-equity incentive | $225,000 |
| Pension and deferred compensation | $0 |
| All other | $5,712 |
| Total | $1,342,627 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: HARROW, INC. DEF 14A filed April 24, 2026, accession 0001493152-26-018912, and prior-year filings. Open the filing on EDGAR.
How this page was built: the HARROW, INC. filed document, accession 0001493152-26-018912. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 30,000 | — | $35.96 |
Per the Outstanding Equity Awards at Fiscal Year-End table in HARROW, INC.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
4 Form 4 lines since the FY2025 proxy (filed April 24, 2026)current to 2026-11-10 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-08-14 | Exercise or conversion derivative | — | 11,250 | $35.96 | 18,750 |
| 2026-08-14 | Exercise or conversion | — | 11,250 | $35.96 | 11,250 |
| 2026-08-14 | Sale | — | 11,250 | $40.00 | 0 |
| 2026-05-15 | Grant or award derivative | — | 10,000 | $0.00 | 10,000 |
The 4 most recent of 4 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
HARROW’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Mark Baum | Chief Executive Officer and Chairman of the Board of Directors | $23,606,274 |
| Andrew Boll | President, Chief Financial Officer and Corporate Secretary | $10,947,441 |
| Amir Shojaei · this page | Chief Scientific Officer | $1,342,627 |
| Francis Mullery | President and Chief Executive Officer, ImprimisRx Division | $1,237,692 |
| John Saharek | Former President and Chief Executive Officer, ImprimisRx Division | $727,421 |
Amir Shojaei's compensation dossier, HARROW
You have read Amir Shojaei's totals and holdings. The dossier adds each equity grant HARROW disclosed for Amir Shojaei and HARROW's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full HARROW compensation record
free company briefThis page is one person within HARROW's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the HARROW proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order HARROW's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are HARROW's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order HROW
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.